BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kennedy RB, Ovsyannikova IG, Thomas A, Larrabee BR, Rubin S, Poland GA. Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine 2019;37:1775-84. [PMID: 30797639 DOI: 10.1016/j.vaccine.2019.02.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Brooks BD, Beland A, Aguero G, Taylor N, Towne FD. Moving beyond Titers. Vaccines 2022;10:683. [DOI: 10.3390/vaccines10050683] [Reference Citation Analysis]
2 Shah AA, Bodewes R, Reijnen L, Boelsums T, Weller CM, Fanoy EB, Veldhuijzen IK. Outbreaks of mumps genotype G viruses in the Netherlands between October 2019 and March 2020: clusters associated with multiple introductions. BMC Infect Dis 2021;21:1035. [PMID: 34607555 DOI: 10.1186/s12879-021-06702-7] [Reference Citation Analysis]
3 Anichini G, Gandolfo C, Fabrizi S, Miceli GB, Terrosi C, Gori Savellini G, Prathyumnan S, Orsi D, Battista G, Cusi MG. Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines (Basel) 2020;8:E66. [PMID: 32028593 DOI: 10.3390/vaccines8010066] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Reddy LM, Bloch D, Mallino A, Kumari P, Figueroa J, Kendrick L, Chahroudi A, Tuttle J, Thomas E, Morris CR. Upward Trends of Parotitis and Mumps in Atlanta over a Decade. Glob Pediatr Health 2020;7:2333794X20968676. [PMID: 33195746 DOI: 10.1177/2333794X20968676] [Reference Citation Analysis]
5 Ellul RC, Farrugia R, Pace D. Presternal swelling: remember mumps. Arch Dis Child 2022:archdischild-2022-323931. [PMID: 35470216 DOI: 10.1136/archdischild-2022-323931] [Reference Citation Analysis]
6 Trevisan A, Mason P, Nicolli A, Maso S, Scarpa B, Moretto A, Scapellato ML. Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers. Vaccines (Basel) 2021;9:377. [PMID: 33924547 DOI: 10.3390/vaccines9040377] [Reference Citation Analysis]
7 Riggenbach MM, Haralambieva IH, Ovsyannikova IG, Schaid DJ, Poland GA, Kennedy RB. Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents. Clin Immunol 2021;234:108912. [PMID: 34968746 DOI: 10.1016/j.clim.2021.108912] [Reference Citation Analysis]
8 Zerbo O, Modaressi S, Glanternik JR, Goddard K, Ross P, Lewis N, Klein NP. Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time. Hum Vaccin Immunother 2020;16:3098-102. [PMID: 32401599 DOI: 10.1080/21645515.2020.1756153] [Reference Citation Analysis]
9 Sasaki H, Fukunaga T, Asano A, Suzuki Y, Nakanishi Y, Kondo J, Ishikawa H, Shibata N. A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults. Vaccines (Basel) 2019;7:E118. [PMID: 31546797 DOI: 10.3390/vaccines7030118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Javelle E, Colson P, Parola P, Raoult D. Measles, the need for a paradigm shift. Eur J Epidemiol 2019;34:897-915. [DOI: 10.1007/s10654-019-00569-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Vakkilainen S, Kleino I, Honkanen J, Salo H, Kainulainen L, Gräsbeck M, Kekäläinen E, Mäkitie O, Klemetti P. The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia. Front Immunol 2020;11:2020. [PMID: 32849667 DOI: 10.3389/fimmu.2020.02020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Crooke SN, Riggenbach MM, Ovsyannikova IG, Warner ND, Chen MH, Hao L, Icenogle JP, Poland GA, Kennedy RB. Durability of humoral immune responses to rubella following MMR vaccination. Vaccine 2020;38:8185-93. [PMID: 33190948 DOI: 10.1016/j.vaccine.2020.10.076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zanella B, Boccalini S, Bonito B, Del Riccio M, Tiscione E, Bonanni P, Working Group Dhs, Working Group AOUMeyer, Working Group Ausltc, Bechini A. Increasing Measles Seroprevalence in a Sample of Pediatric and Adolescent Population of Tuscany (Italy): A Vaccination Campaign Success. Vaccines (Basel) 2020;8:E512. [PMID: 32911762 DOI: 10.3390/vaccines8030512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 El Zarif T, Kassir MF, Bizri N, Kassir G, Musharrafieh U, Bizri AR. Measles and mumps outbreaks in Lebanon: trends and links. BMC Infect Dis 2020;20:244. [PMID: 32216754 DOI: 10.1186/s12879-020-04956-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Bartelme RR. Anthroposophic Medicine: A Short Monograph and Narrative Review-Foundations, Essential Characteristics, Scientific Basis, Safety, Effectiveness and Misconceptions. Glob Adv Health Med 2020;9:2164956120973634. [PMID: 33457106 DOI: 10.1177/2164956120973634] [Reference Citation Analysis]
16 Han SB, Park SH, Yi Y, Ji SK, Jang SH, Park MH, Lee JE, Jeong HS, Shin S. Measles seroprevalence among healthcare workers in South Korea during the post-elimination period. Hum Vaccin Immunother 2021;:1-5. [PMID: 33689571 DOI: 10.1080/21645515.2021.1888623] [Reference Citation Analysis]
17 Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, Ten Hulscher HI, Kerkhof J, van der Klis FR, van Binnendijk RS. A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults. J Infect Dis 2020;221:902-9. [PMID: 31112277 DOI: 10.1093/infdis/jiz188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
18 Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Front Immunol. 2020;11:1181. [PMID: 32670279 DOI: 10.3389/fimmu.2020.01181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
19 Holka J, Pawlak K, Ciepiela O. Seroprevalence of IgG antibodies against measles in a selected Polish population - do we need to be re-vaccinated? Cent Eur J Immunol 2019;44:380-3. [PMID: 32140049 DOI: 10.5114/ceji.2019.92789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Ferlito C, Biselli R, Visco V, Cattaruzza MS, Capobianchi MR, Castilletti C, Lapa D, Nicoletti L, Marchi A, Magurano F, Ciccaglione AR, Chionne P, Madonna E, Donatelli I, Calzoletti L, Fabiani C, Biondo MI, Teloni R, Mariotti S, Salerno G, Picchianti-Diamanti A, Salemi S, Caporuscio S, Autore A, Lulli P, Borelli F, Lastilla M, Nisini R, D'Amelio R. Immunogenicity of Viral Vaccines in the Italian Military. Biomedicines 2021;9:87. [PMID: 33477366 DOI: 10.3390/biomedicines9010087] [Reference Citation Analysis]
21 Won H, Kim AR, Yoo JS, Chung GT, Kang HJ, Kim SJ, Kim SS, Lee JW. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea. Vaccine 2021;39:1870-6. [PMID: 33642163 DOI: 10.1016/j.vaccine.2021.01.039] [Reference Citation Analysis]
22 Connell AR, Connell J, Leahy TR, Hassan J. Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines? Front Immunol 2020;11:2089. [PMID: 33072071 DOI: 10.3389/fimmu.2020.02089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]